Understanding Avastin for Glioblastoma Treatment
Bevacizumab, known under its trade name Avastin, represents a groundbreaking medication for combating cancer by inhibiting the formation of fresh blood vessels that could nourish a tumor. The FDA has granted approval for Avastin for glioblastoma (GBM) management among adult patients who have experienced cancer progression following prior treatment, which includes recurrent glioblastoma (rGBM). Bevacizumab …
Understanding Avastin for Glioblastoma Treatment Read More »